Latest Capital Raisings News

Page 17 of 678
Racura Oncology's FY2026 results reveal a widening loss despite a 22% revenue dip, underpinned by significant scientific progress on its lead drug targeting the elusive MYC gene and a robust $34.3 million cash position.
Ada Torres
Ada Torres
25 Aug 2026
Terragen Holdings posted a slight increase in net loss to AUD 3.75 million for FY2026, while advancing key commercial trials and securing a $7 million equity raise to fuel growth.
Ada Torres
Ada Torres
25 Aug 2026
AIX has acquired an 8% holding in AI powerhouse Databricks during its US$5 billion funding round, marking a significant expansion in the trust’s AI-focused portfolio.
Sophie Babbage
Sophie Babbage
25 Aug 2026
HighCom Limited’s FY26 results reveal a sharp revenue drop and widening loss driven by a US Government shutdown, but a strengthened leadership team and expanded global sales pipeline set the stage for recovery.
Victor Sage
Victor Sage
25 Aug 2026
WAM Income Maximiser has secured $172.4 million through a multi-part capital raise, increasing its assets by more than half and maintaining a strong fully franked dividend yield.
Victor Sage
Victor Sage
25 Aug 2026
Piche Resources completed a $2.53 million entitlement offer, raising $728,324 from shareholders, with the underwriter stepping in to cover a $1.85 million shortfall. New shares and options are set to trade from 31 August 2026.
Maxwell Dee
Maxwell Dee
25 Aug 2026
Anax Metals has lifted the Mons Cupri Mineral Resource by nearly a quarter, underpinning its push towards a Final Investment Decision later this year.
Maxwell Dee
Maxwell Dee
25 Aug 2026
Horizon Gold has unveiled significant gold intercepts from recent RC drilling at its Gum Creek Project, notably confirming an 800-metre southern extension at the Howards prospect alongside promising results at Heron South and Melbourne Bitter, underpinning potential resource growth ahead of planned updates.
Maxwell Dee
Maxwell Dee
25 Aug 2026
Prescient Therapeutics launches a $7 million Share Purchase Plan at an 18.8% discount to fund advancement of its PTX-100 cancer therapy beyond a key 2026 Dose Optimisation Committee review.
Ada Torres
Ada Torres
25 Aug 2026
Jcurve Solutions (ASX:JCS) posted a significant financial turnaround in FY2026, with revenue climbing 16.3% to $13.28 million and normalised EBITDA more than doubling to $1.88 million, underpinned by disciplined cost control and recurring revenue growth.
Sophie Babbage
Sophie Babbage
25 Aug 2026
Nanoveu’s half-year report reveals a sharp drop in revenue and a widening net loss, offset by key technological milestones including a 16nm AI chip tape-out, drone efficiency gains, and a strategic robotics acquisition.
Sophie Babbage
Sophie Babbage
24 Aug 2026
Pacific Resources Limited (ASX: PXR) completed a strategic pivot in FY2026, acquiring the high-grade Snowstorm Gold Project in Victoria and expanding exploration in Tasmania, while maintaining its Queensland coal assets. The company reported a $769K loss on no operating revenue, supported by a $1.5 million capital raise.
Maxwell Dee
Maxwell Dee
24 Aug 2026

Browse the archive

Full archive